Assisted reproductive technology
|
|
- Barnaby Leonard
- 5 years ago
- Views:
Transcription
1 Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo transfer at the University of Ottawa: an inefficient therapy for tubal infertility* Paul Claman, M.D. t Minerva Domingo, M.D. Peter Garner, M.D. Arthur Leader, M.D. John E. H. Spence, M.D. Goal Program, Department of Obstetrics and Gynecology, Ottawa Civic Hospital, Uaiversity of Ottawa, Ottawa, Ontario, Canada Objective: To describe our experience with natural cycle IVF making clinical and endocrine comparisons with our standard stimulated cycle IVF program. Design: We attempted 75 natural IVF-ET cycles with hcg given to preempt the LH surge and compared these with 450 attempts at standard superovulation IVF -ET done in our unit during the same time period. Patients: Natural cycle patients are normally ovulating women < age 38. Superovulation IVF ET patients are all <41 years old. Patients in both groups had partners with normal semen parameters and tubal factor infertility. Main Outcome Measures: Cancellation rates, pregnancy rates per egg retrieval, per ET procedure, and luteal phase E 2 :P ratios of the treatment cycles are compared. Results: There were 35 of 75 (47%) natural cycle and 112 of 450 (25%) superovulation cycle cancellations. An egg was retrieved in only 24 of 40 (60%) natural cycles and 336 of 338 (99%) superovulation egg retrieval procedures. Pregnancy rates per ovum pick-up procedure were significantly higher: 65 of 338 (19%) in the superovulation versus 2 of 40 (5%) in the natural cycle groups. Pregnancy rates per ET were not significantly different between natural IVF -ET, 2 of 18 (11 %) and superovulation IVF-ET, 65 of 298 (22%). The E 2 :P ratios 5 days after ET were similar in both groups at 18 ± 4 after natural IVF-ET and 21 ± 18 after superovulation IVF-ET. Conclusions: [1] Cancellation rates for natural cycle IVF are very high. [2] Midluteal E 2 :P ratios are the same in both groups. [3] Pregnancy rates per egg retrieval are significantly lower for natural versus superovulation IVF-ET. [4] In our experience, natural cycle IVF-ET is an inefficient therapy for tubal infertility compared with superovulation IVF-ET. Fertil Steril 1993;60: Key Words: In vitro fertilization, embryo transfer, natural cycle, unstimulated cycle The first successful pregnancy after human IVF - ET was done by retrieving an oocyte during an unstimulated natural menstrual cycle (1). With refinements in controlled ovarian stimulation, natural Received January 22, 1993; revised and accepted April 19, * Presented at the 48th Annual Meeting of The American Fertility Society, New Orleans Louisiana, November 2 to 5, t Reprint requests: Paul Claman, M.D., 737 Parkdale Avenue, Ottawa, Ontario, Canada K1 Y 4E9. cycle IVF was abandoned in the early 1980s in favor of superovulation IVF leading to higher pregnancy rates (PRs) per egg retrieval procedure than could be achieved in the natural cycle (2). In recent years, the technological advances of ultrasound (US) guided egg retrieval replacing laparoscopy and a better understanding of the LH surge to ovulation interval (3) have rekindled interest in the use of unstimulated cycles for IVF -ET in the treatment of infertility (4-7). We attempted 75 natural cycle IVF -ET cycles and compared these with 450 superovulation cycle attempts at IVF -ET done during 298 Claman et al. Natural cycle versus superovulation IVF-ET Fertility and Sterility
2 the same time frame under the same laboratory conditions. MATERIALS AND METHODS Seventy-five natural cycle IVF-ET cycles were studied and compared with 450 superovulation IVF -ET cycles. Both groups of patients had tubal factor infertility with normal semen parameters (8). Patients with tubal factor infertility were offered natural cycle IVF-ET as an option to a standard IVF-ET superovulation protocol, but allocation was not randomized. Inclusion criteria for the natural cycle protocol include the following: age < 38, normal ovulatory function (regular cycles, normal BBT chart, and in-phase late luteal timed endometrial biopsy), serum FSH <10 on cycle days 3 to 5, and both ovaries accessible to transvaginal US-guided egg retrieval. Inclusion criteria in the superovulation IVF-ET-treated patients were age < 41 years in addition to the criteria noted above. The natural cycle protocol involved drawing a baseline serum LH before cycle day 9 and monitoring daily serum LH, E2, and US starting on cycle day 10. Human chorionic gonadotropin (Profasi; Serono Canada, Mississauga, Ontario, Canada) 2,500 IU 1M (30 cases) or 5,000 IU 1M (10 cases) was given 34 hours (35 cases) or 36 hours (5 cases) before ovum pick-up when a follicle> 18 mm diameter was seen on US in association with an E2 > 180 pg/ml (650 pmol/l). Cycles were canceled if LH levels were found to be more than two times the baseline value or if E2 levels fell during monitoring. Egg retrieval was done by transvaginal guided US. Analgesia at ovum pick-up included 50 to 200 Ilg IV fentanyl and in some cases medazolam 1 mg. Lidocaine, 0.5%, was injected into the vaginal mucosa of the lateral vaginal fornices after preparing the vagina with a normal saline rinse. Patients received cefazolin, 1 g IV, before ovum pick-up. Standard superovulation protocol used leuprolide acetate (Lupron; Abbott Pharmaceuticals, Montreal, Quebec, Canada) in the midluteal phase before hmg therapy as previously described (9). Fertilization with Percoll-treated sperm (10) and ET of a maximum of four embryos was performed in the same way for both superovulation and natural cycle IVF-ET. Luteal phase support using hcg 1,500 IU 1M every 3 days for three doses starting 1 day after ovum pick-up was given in both natural cycle and superovulation IVF -ET cycle patients. Progesterone luteal support was used in superovulation cycles when E2 was >2,700 pg/ml (10,000 pmol/l) at the time of the preovum pick-up hcg 5,000 IU ovulation trigger. Progesterone in oil (Steris Labs, Phoenix, AZ) 12.5 mg/d 1M was given starting on the day after the hcg trigger. On the day of ET, the P dosage was increased to 25 mg/d. If pregnant, P was continued until fetal heart activity was seen on US. Serum E2 and P were drawn 5 days after ET in both natural and superovulation IVF -ET treatment cycles. Endocrine tests (E2, P, FSH, LH, and (3-hCG) were all done in serum using commercial RIA kits (FSH, LH, and (3-HCG by Amerlex-M, Amersham Canada Ltd, Ontario, Canada and E2 by Pantex, Santa Monica, CA). Estradiol was assayed on the day of hcg trigger, day of ET, and 9 days after the hcg trigger (i.e., midluteal phase). Progesterone was assayed on the day of ET and 9 days after the hcg trigger. Pregnancy testing with a serum (3- hcg assay was done 17 days after ET. Pregnancy is defined by the identification of a gestational sac on US done at least 4 weeks after ET. A two-tailed Student's t-test was used to compare endocrine data after testing for normality, and x2 or Fisher's exact test was used where appropriate. RESULTS There were 35 of 75 (47%) natural cycle and 112 of 450 (25%) superovulation cycle cancellations (P < ) (Table 1). An egg was retrieved at ovum pick -up in only 24 of 40 (60%) natural cycles and in 336 of 338 (99%) superovulation ovum pick-up procedures (P < ). Of those ovum pick-ups producing at least one egg, there was a trend to having a better chance of at least one embryo being available for transfer in the superovulation IVF cycles with 18 of 24 (60%) natural IVF -ET and 298 of 336 (89%) superovulation cases, resulting in at least one embryo for transfer (P = 0.098). Pregnancy rates per cycle initiated were much higher in the superovulation 65 of 450 (14.4%) versus the natural cycle cases 2 of 75 (2.7%) P = Pregnancy rates per ovum pick-up were also significantly higher in the superovulation 65 of 338 (19%) versus 2 of 40 (5%) in the natural cycle groups (P = 0.044). Pregnancy rate per ET procedure appear similar in both groups with 2 of 18 (11 %) pregnant after natural IVF -ET and 65 of 298 (22%) after superovulation IVF-ET (P = 0.434). Miscarriage or ectopic pregnancies appear similar in both groups, with pregnancies going to term in 48 of 65 (74%) superovulation and 2 of 2 natural IVF-ET Vol. 60, No.2, August 1993 Claman et al. Natural cycle versus superovulation IVF-ET 299
3 Table 1 Results of Natural Cycle IVF-ET Versus Superovulation IVF-ET Nautral cycle IVF-ET Superovulation IVF-ET Probability No. cycles started No. of cancellations ;:,:1 egg found per ovum pick-up procedure ;:,:1 cleaving embryo per ovum pick-up if egg retrieved Pregnancies per ET procedure Pregnancies per ovum pick-up procedure Term pregnancies per ovum pick-up procedure Pregnancies per cycle started E 2 :P ratio 5 days after ovum pick-up* (47)* 24/40 (60) 18/24 (60) 2/18 (11) 2/40 (5) 2/40 (5) 2/75 (2.7) 18 ± (25) 336/338 (99) 298/336 (89) 65/298 (22) 65/338 (19) 48/338 (14) 65/450 (14.4) 21 ± 18 < < NSt NSt * Values in parentheses are percents. t NS, not significant. :j: Values are means ± SD. pregnancies (P = 0_99). There were 13 of 65 (20%) multiple pregnancies (8 twins, 4 triplets, and 1 quadruplet) in the superovulation IVF-ET group. Both pregnancies from natural cycle IVF-ET were singleton. The E2:P ratio 5 days after ET was similar in both groups at 18 ± 4 after natural IVF-ET and 21 ± 18 (n = 67) after superovulation IVF -ET (P = 0.556). Furthermore, the E2:P ratio 5 days after ET was not statistically different between natural IVF -ET 18 ± 4 or superovulation IVF -ET whether hcg (n = 39) 17 ± 8 (P = 0.7) or P (n = 28) 28 ± 25 (P = 0.227) was used for luteal support. Baseline LH:FSH ratios in natural cycle IVF -ET did not help predict which patients would be canceled with LH:FSH = ± in canceled versus ± in noncanceled cases (P = 0.6). The baseline LH:FSH of ± in patients canceled because of a premature LH surge was not significantly different from ± in nonsurgers. The E2 on the day of hcg trigger was the same whether an egg was (234 ± 67 pg/ml [858 ± 245 pmol/ml» or was not (241 ± 74 pg/ml [886 ± 272 pmol/ml» retrieved at ovum pick-up in the natural IVF -ET group. DISCUSSION The first successful IVF -ET trials used laparoscopic oocyte retrieval timed to the LH surge in unstimulated cycles. Forty-four oocytes were retrieved in 68 laparoscopic procedures. Because only 65 % of laparoscopic procedures led to successful retrieval of an egg and 68% of these eggs fertilized and cleaved for transfer (1), efforts at improving the success of IVF -ET concentrated on developing protocols for stimulating multiple follicular development (2). The importance of ensuring the availability of mature oocytes after an egg retrieval procedure was especially compelling in an era when laparoscopy and general anesthesia were needed for follicle aspiration. However, availability of minimally invasive methods for follicle aspiration (11) and a better understanding of LH surge physiology (3) have led to renewed interest in performing IVF ET in natural cycles. The potential advantages of natural cycle IVF ET are as follows. First, the costs to patient and facility are lower because only hcg is given and the amount of hormone and US monitoring needed is halved. Second, without hmg stimulation, the risks of ovarian hyperstimulation syndrome and multiple pregnancy are obviated. Third, the emotional "roller coaster" of IVF -ET is minimized by removing the almost obsessive daily concerns surrounding the ovarian response to hmg. Fourth, with maintenance of physiological steroid hormone concentrations found in the natural cycle, there may be a higher PR per transferred embryo. Although some centers have attempted natural cycle IVF -ET timed to the endogenous LH surge (5, 7), we and others (4, 6) chose to preempt the endogenous LH surge with hcg to ensure adequate time between LH-like stimulation and ovum pick-up (3) and to prevent the need to perform ovum pick-up procedures in late afternoon or early evening hours, which are impractical in our clinic setting. Although monitoring for natural cycle IVF-ET is much less intensive than during the protocol for superovulation IVF -ET, the cancellation rate of 47% was believed to be unacceptable in the natural IVF -ET cycle protocol, despite careful attention to excluding women with ovulatory dysfunction. Most cancellations occurred because of the endogenous LH surge despite choosing a low morning value E2 of >180 pg/ml (650 pmol/l) to indicate a later hcg injection (given at 10:00 to 11:00 P.M.). The 47% cancellation rate was significantly higher than 300 Claman et ai. Natural cycle versus superovulation IVF-ET Fertility and Sterility
4 the 25% cancellation rate in the superovulation protocol despite the fact that recent hmg protocol adjustments have been made to reduce an unacceptably high cancellation rate for superovulation IVF-ET employing GnRH analogue down regulation with hmg administration (12). Although transvaginal US-guided follicle aspiration is less traumatic than laparoscopy, it is not without risk of infection or bleeding and does involve intensive preparation with the presence of physician, nursing, and laboratory personnel as well as culture media preparation. In this experience with natural cycles, successful aspiration of the dominant follicle with a 3- to 4-mL aspirate was almost always achieved, but egg retrieval was only successful in 60% of these ovum pick-up procedures, despite multiple attempts at flushing. This is compared with a 99% chance of retrieving at least one egg in a superovulation cycle. This low success rate for retrieving the egg in unstimulated cycles is similar to those originally reported by laparoscopy (1) but lower than the 98% (4) and> 100% (1.6 eggs per aspiration) (6) reported by others using a similar protocol with hcg preempting the LH surge in natural cycles. Of those groups reporting the use of the endogenous LH surge alone in unstimulated cycles, oocytes were obtained in 88% to 100% of cycles (5, 7). The only explanation for the lower 60% successful egg retrieval rate in this series, compared with that reported by others, is possibly the policy of canceling cases with an endogenous LH surge. Canceling LH surge cycles was also the reported protocol at the University of Southern California (6). Operator inexperience is an unlikely problem, noting that we have performed five to eight transvaginal US-guided ovum pick-up procedures in superovulated cycles weekly since early 1989 with almost all procedures yielding more than one egg. With an egg available after ovum pick-up, fertilization leading to a cleaving (2- to 8-cell stage) embryo available for transfer occurred 60% of the time in unstimulated cycles. With multiple eggs available most of the time after superovulation IVF-ET, at least one cleaved embryo was transferred in 89% of these cases. With only 18 ET procedures completed after natural cycle IVF -ET, there was no demonstratable significant difference in the chances for ET after ovum pick-up (P = 0.098) compared with superovulation IVF-ET cases. A 60% overall fertilization rate per egg is also observed in our IVF -ET cycles done for tubal disease when superovulation is employed. These rates seem lower than the 85% to 100% fertilization rates per egg after unstimulated IVF -ET reported by others (4-7) but similar to fertilization rates reported by most IVF ET clinics after superovulation IVF-ET (13). A higher fertilization rate per egg after unstimulated IVF -ET might be expected because the single egg retrieved has matured before the LH stimulus, as opposed to a somewhat heterogeneous cohort of eggs aspirated from both small and large follicles after superovulation IVF-ET. However, fertilization rates of 60% even after an egg is aspirated in a natural IVF -ET cycle may be a realistic expectation for many IVF -ET laboratories. Pregnancy rates per ovum pick-up are higher at 19% for stimulated versus 5% for natural cycle IVF-ET (P = 0.044). These higher PRs per ovum pick-up for stimulated cycles would be expected because of the higher chance for eggs and embryos to be transferred after an ovum pick-up in superovulation IVF -ET cases. The two pregnancies in the 40 natural cycle ovum pick-up cases went to term with 48 of 65 superovulation IVF-ET pregnancies (26% early pregnancy loss) going to term after 338 ovum pick-up procedures. With only two natural cycle IVF -ET pregnancies, both going to term, there was no demonstratable difference in pregnancy loss rates between natural and superovulation IVF -ET. Pregnancy rates per ET procedure are similar after both natural (11 %) and superovulation IVF ET (22%) (P = 0.434) despite the fact that between one and four embryos (mean = 3) were transferred after superovulation IVF-ET. High luteal E 2 :P ratios have been implicated as a reason for lower than expected rates of implantation per embryo transferred after super ovulated IVF-ET (9). There was no difference between the E 2 :P ratios in the midluteal phase of natural cycle IVF -ET versus that observed after superovulation IVF-ET. In conclusion, Cancellation rates after the start of daily monitoring for natural cycle IVF -ET are very high. Significantly more natural cycle IVF -ET egg retrieval procedures end without retrieving an egg at all compared with superovulation IVF -ET. This leads to large numbers of expensive and unproductive procedure room and gamete laboratory preparations. In this protocol, natural cycle IVF ET was not found to be an efficient therapy for tubal infertility when compared with superovulation IVF -ET. REFERENCES 1. Edwards RG, Steptoe PC, Purdy JM. Establishing full term human pregnancies using cleaving embryos grown in vitro. Br J Obstet GynaecoI1980;87: Vol. 60, No.2, August 1993 Claman et al. Natural cycle versus superovulation IVF-ET 301
5 2. Fishel SB, Edwards RG, Purdy JM, Steptoe PC, Webster J, Walters E, et al. Implantation, abortion and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin. J Vitro Fert Embryo Transfer 1985;2: Taymor ML, Seibel MM, Smith D, Levesue L. Ovulation timing by luteinizing hormone assay and follicle puncture. Obstet GynecoI1983;62: Foulot H, Ranoux C, Dubuisson J-B, Rambaud D, Aubriot F -X, Poirot C. In vitro fertilization without ovarian stimulation: a simplified protocol applied in 80 cycles. Fertil Steril 1989;52: Ramsewak SS, Cooke ID, Li T-C, Kumar A, Monks NJ, Lenton EA. Are factors that influence oocyte fertilization also predictive? An assessment of 148 cycles of in vitro fertilization without gonadotropin stimulation. Fertil Steril 1990;54: Paulson FJ, Sauer MV, Francis MM, Macaso TM, Lobo RA. In vitro fertilization in unstimulated cycles: the University of Southern California experience. Fertil Steril 1992;57: Taymor ML, Ranoux CJ, Gross GL. Natural oocyte retrieval with intravaginal fertilization: a simplified approach to in vitro fertilization. Obstet Gynecol 1992;80: World Health Organization. WHO Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 2nd ed. Cambridge: The Press Syndicate of the University of Cambridge, Claman P, Domingo M, Leader A. Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone. Hum Reprod 1992;7: Tanphaichitr N, Agulnick A, Seibel MM, Taymor ML. Comparison of the in vitro fertilization rate by human sperm capacitated by multiple tube swim up and percoll gradient centrifugation. J Vitro Fert Embryo Transfer 1988;5: Ramsewak SS, Kumar A, Welsby R, Mowforth A, Lenton EA, Cooke ID. Is analgesia required for transvaginal single follicle aspiration in in vitro fertilization? A double blind study. J Vitro Fert Embryo Transfer 1990;7: Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Kempton W, Huynh D. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 1989;51: Medical Research International, Society for Assisted Reproductive Technology, The American Fertility Society. In vitro fertilization-embryo transfer (lvf-et) in the United States: 1989 results from the IVF-ET Registry. Fertil Steril 1991;55: Claman et al. Natural cycle versus superovulation IVF-ET Fertility and Sterility
Utility of in vitro fertilization at diagnostic laparoscopy*
FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.
More informationMilan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,
FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol
More informationBulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t
FERTILITY AND STERILITY Copyright c 1992 The American Fertility Society Vol. 57, No.6, June 1992 Printed on acid-free paper in U.S.A. The outcome of in vitro fertilization and embryo transfer in women
More informationDepartment of Gynaecology and Reproductive Medicine, University Hospital, University of Western Ontario, London, Ontario, Canada
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationConception rate after in vitro fertilization in patients who conceived in a previous cycle
FERTILITY AND STERILITY Copyright
More informationMinimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age
FERTILITY AND STERILITY VOL. 81, NO. 4, APRIL 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Minimal stimulation using recombinant
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More informationFixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol
Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationInfertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations
Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationSignificance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization*
FERTILITY AND STERILITY Copyright e 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program
More informationEgg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer
FERTILITY AND STERILITY Copyright tl 1989 The American Fertility Society Printed on acid-free paper in U. S.A. Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization
More informationProspective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in an in vitro fertilization program
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Prospective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationRecent Developments in Infertility Treatment
Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other
More informationOvarian response in three consecutive in vitro fertilization cycles
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION
More informationThe predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt*
FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. The predictive value of idiopathic failure to fertilize on the first in vitro fertilization
More informationReproductive Endocrinology & Infertility Glossary
Reproductive Endocrinology & Infertility Glossary The following is a glossary of terms you may hear during your association with the University of Mississippi Health Care's reproductive endocrinology and
More informationGonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome
FERTILITY AND STERILITY Copyright e 1993 The American Fertility Society Vol. 59, No.3, March 1993 Printed on acid-free paper in U.S.A. Gonadotropin-releasing hormone agonist reduces the miscarriage rate
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More information* Present address: Foothills Hospital, Calgary, Alberta, Canada.
FERTILITY AND STERILITY Copyright 1993 The American Fertility Society Vol. 59, No. 6, June 1993 Printed on acid-free paper in U.S.A. A randomized trial of in vitro fertilization versus conventional treatment
More informationRisk factors for spontaneous abortion in menotropintreated
FERTILITY AND STERILITY Copyright ~ 1987 The American Fertility Society Vol. 48, No. 4, October 1987 Printed in U.S.A. Risk factors for spontaneous abortion in menotropintreated women Michael Bohrer, M.D.*
More information10.7 The Reproductive Hormones
10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid
More informationPuerto Rico Fertility Center
Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationK.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1
Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationLUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY*
FERTILITY AND STERILITY Copyright c 1978 The American Fertility Society Vol. 29, No.3, March 1978 Printed in U.S.A. LUTEINIZED UNRUPTURED FOLLICLE SYNDROME: A SUBTLE CAUSE OF INFERTILITY* JAROSLA V MARIK,
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationOvulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age*
FERTILITY AND STERILITY Vol. 58, No.4, October 1992 Copyright It! 1992 The American Fertility Society Printed on acid-free paper in U. S.A. Ovulation induction in women age 40 and older: the importance
More informationSuperovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*
aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is
More informationPrinciples of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationThe effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles
FERTILITY AND STERILITY Vol. 65, No.3, March 1996 Copyright t';, 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. s. A. The effects of prior gravidity on the outcomes of
More informationIn Vitro Fertilization What to expect
Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,
More informationPremature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles
Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra
More informationIVF Protocols: Hyper & Hypo-Responders, Implantation
IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationEffect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer cycles*
FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Effect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer
More informationClomiphene-acetyl cysteine combination as a new protocol to a friendly IVF cycle
Middle East Fertility Society Journal Vol. 10, No. 2, 2005 Copyright Middle East Fertility Society Clomiphene-acetyl cysteine combination as a new protocol to a friendly IVF cycle Ahmed Y Rizk, M.D. *
More information' ' ' ' ' ' ' ' COMPARISON BETWEEN HIGHLY PURIFIED--FSH AND HMG FOR SUPEROVULATION IN WOMEN UNDERGOING IN VITRO FERTILIZATION ORIGINAL RESEARCH
' ' ' ' ORIGINAL RESEARCH ' ' ' ' COMPARISON BETWEEN HIGHLY PURIFIED--FSH AND HMG FOR SUPEROVULATION IN WOMEN UNDERGOING IN VITRO FERTILIZATION Pierre Miron, MD, FRCSC, 1 Robert Casper, MD, FRCSC,2 Louise
More informationPrognostic value of day 3 estradiol on in vitro fertilization outcome*
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization
More informationSupraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles
Human Reproduction Vol.17, No.1 pp. 83 87, 2002 Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Joseph E.Peña, Peter L.Chang 1, Lai-King Chan, Khaled
More informationBlastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2 3 embryo transfer cycles: a prospective, randomized study
FERTILITY AND STERILITY VOL. 81, NO. 3, MARCH 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Blastocyst-stage embryo transfer
More informationAssisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION
( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation
More informationUW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT
UW MEDICINE PATIENT EDUCATION In Vitro Fertilization How to prepare and what to expect This handout tells how to prepare for and what to expect when you go through a cycle of in vitro fertilization. It
More informationNew York Science Journal 2014;7(4)
The Minimal Stimulation Protocol for ICSI: An Alternative Protocol for Ovarian Stimulation Adel Elsayed Ibrahim, MD Assisted Reproductive Unit Azhar University Adel.sayed29@gmail.com Abstract: Background:
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationIn Vitro Fertilization
Patient Education In Vitro Fertilization About the treatment This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this
More informationUtility of color Doppler indices of dominant follicular
Ultrasound Obstet Gynecol 2002; 20: 592 596 Utility of color Doppler indices of dominant follicular Blackwell Science, Ltd blood flow for prediction of clinical factors in in vitro fertilization-embryo
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Infertility Injectables Table of Contents Coverage Policy... 1 General Background...16 Coding/Billing Information...20 References...20 Effective Date...
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationPatient Information: Patient Name: Date of Birth:
Weill Cornell Medicine Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Informed Consent for Oocyte (Egg) Cryopreservation Patient Information: Part 1: I have requested to be treated
More informationin vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationFertility assessment and assisted conception
Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.
More informationAMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Formerly The American Fertility Society OVULATION DETECTION A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive
More informationSonographic determination of a possible adverse effect of domiphene citrate on endometrial growth
Human Reproduction vol.5 no.6 pp.670-674, 1990 Sonographic determination of a possible adverse effect of domiphene citrate on endometrial growth Yael Gonen 1 and Robert F.Casper Division of Reproductive
More informationInfertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?
Infertility (female factors). In another one third of cases, infertility is due to the man (male factors). The remaining cases are caused by a mixture of male and female factors or by unknown factors.
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationThe Presence of Hydrosalpinx May Not Adversely Affect the Implantation and Pregnancy Rates in In Vitro Fertilization Treatment1
CLINICAL ASSISTED REPRODUCTION The Presence of Hydrosalpinx May Not Adversely Affect the Implantation and Pregnancy Rates in In Vitro Fertilization Treatment1 ERNEST HUNG-YU NG,2,3 WILLIAM SHU-BIU YEUNG,2
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER
*40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility
More informationAcupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection
Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Sandra L. Emmons, MD Phillip Patton, MD Source: Medical Acupuncture, A Journal For Physicians By Physicians Spring
More informationWeb Activity: Simulation Structures of the Female Reproductive System
differentiate. The epididymis is a coiled tube found along the outer edge of the testis where the sperm mature. 3. Testosterone is a male sex hormone produced in the interstitial cells of the testes. It
More informationA novel ovarian stimulation protocol for use with the assisted reproductive technologies*
FERTILITY AND STERILITY Vo!' 60, No.5, November 1993 Copyright 1993 The American Fertility Society Printed on acid-free paper in U. S. A. A novel ovarian protocol for use with the assisted reproductive
More informationProgramming in vitro fertilization for a 5- or 3-day week
Ass~st.d.reproductive tec"no'ogy FERTILITY AND STERILITY Copyright I[J 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Programming in vitro fertilization for a 5- or 3-day week
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationOriginal Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2
Original Article Comparison of Letrozole and Clomiphene Citrate Efficacy along with Gonadotrophins in Controlled Ovarian Hyperstimulation for Intrauterine Insemination Cycles Fauzia HaqNawaz 1*, Saadia
More informationA controlled study of gonadotropin-releasing hormone agonist (buserelin acetate*) for folliculogenesis in routine in vitro fertilization patients
FERTILITY AND STERILITY Copyright" 1991 The American Fertility Society Vol. 56, No. 3, September 1991 Printed on acid-free paper in U.S.A. A controlled study of gonadotropin-releasing hormone agonist (buserelin
More informationClinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.
UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.
*40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print
More informationProspective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program
FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Printed on acid-free paper in U. s. A. Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in
More informationReproduction and Development. Female Reproductive System
Reproduction and Development Female Reproductive System Outcomes 5. Identify the structures in the human female reproductive system and describe their functions. Ovaries, Fallopian tubes, Uterus, Endometrium,
More informationComparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization
Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,
More informationIs the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion
F, V & V IN OBGYN, 2010, MONOGRAPH: 36-41 Artificial insemination Is the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion Arne SUNDE 1, Jarl
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationIn Vitro Fertilization and Embryo Transfer
Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,
More informationArticle Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles
RBMOnline - Vol 13. No 3. 2006 326 330 Reproductive BioMedicine Online; www.rbmonline.com/article/1911 on web 13 June 2006 Article Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist
More informationArticle Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination
RBMOnline - Vol 13. No 2. 2006 208-212 Reproductive BioMedicine Online; www.rbmonline.com/article/2334 on web 30 May 2006 Article Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine
More informationVaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer
Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Mohamed F. Mitwally, M.D., H.C.L.D., a Michael P. Diamond,
More informationEffects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment
FERTILITY AND STERILITY VOL. 74, NO. 5, NOVEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Effects of functional
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationModified natural cycle IVF and mild IVF: a 10 year Swedish experience
Reproductive BioMedicine Online (2010) 20, 156 162 www.sciencedirect.com www.rbmonline.com ARTICLE Modified natural cycle IVF and mild IVF: a 10 year Swedish experience Arthur Aanesen *, Karl-Gösta Nygren,
More informationAnti-Mullerian hormone (AMH) as predictor of ovarian reserve
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Shembekar CA et al. Int J Reprod Contracept Obstet Gynecol. 2017 Sep;6(9):4006-4010 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174053
More informationReproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands
Reproductive System Testes gametogenesis hormones Accessory reproductive organs Reproductive tract & Glands transport gametes provide nourishment for gametes Hormonal regulation in men Hypothalamus - puberty
More informationPerformance of patients with a ''frozen pelvis" in an in vitro fertilization program
FERTILITY AND STERILITY Copyright 1987 The American Fertility Society Printed in U.8A. Performance of patients with a ''frozen pelvis" in an in vitro fertilization program David Molloy, F.R.A.C.O.G.*t
More informationCauses of Infertility and Treatment Options
Causes of Infertility and Treatment Options Dr Mrs.Kiran D. Sekhar Former vice President-FOGSI Former Chairperson- Genetics and Foetal medicine-fogsi Founder and Medical Director-Kiran Infertility centre
More informationUnderstanding Infertility, Evaluations, and Treatment Options
Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationLaboratoires Genevirer Menotrophin IU 1.8.2
Important missing information VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Infertility is when a woman cannot get pregnant (conceive) despite having regular unprotected sexual
More informationDepartment of Obstetrics and Gynecology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas
FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Vol. 56, No. 2, August 1991 Printed on ocid-free paper in U.S.A. Follicular size at the time of human chorionic gonadotropin administration
More information